Bispecific antibody targeting CD40 and HER2 potentiates therapeutic efficacy by reprogramming macrophages within the tumour microenvironment
靶向CD40和HER2的双特异性抗体通过重编程肿瘤微环境中的巨噬细胞来增强治疗效果。
期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.70428
Li, Na; Li, Ruonan; Ma, Qiongqiong; Zhang, Xiaoqi; Ma, Wenxuan; Wang, Yi; Duan, Baoxin; Yang, Kailu; Zhang, Dongping; Zhang, Jiashuo; Gu, Manping; Wu, Yaxing; Sun, Jiajin; Wang, Huawei; Li, Anqi; Chen, Fuquan; Bai, Yiyang; Tian, Yujie; Li, Xin; Yan, Yingbin; Wang, Wei; Zhang, Hongkai; Wang, Yuan
巨噬细胞
肿瘤
T细胞
HER2
肿瘤免疫
巨噬细胞
CD40
细胞生物学
肿瘤微环境
CD4
免疫/内分泌